Defining On-Treatment Remission in Plaque Psoriasis

Overview of attention for article published in JAMA Dermatology, August 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 5 news outlets
twitter: 6 X users
video: 1 YouTube creator

bluesky: 2 Bluesky users
podcasts: 3 podcasts

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 Bluesky posts from 2 Bluesky users, with an upper bound of 2,205 followers.

Consensus from the National Psoriasis Foundation defines on-treatment remission in plaque psoriasis to improve patient therapy alignment. PMID:40531503, JAMA Dermatol 2025 https://doi.org/10.1001/jamadermatol.2025.1625 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪

National Psoriasis Found. Consensus Defines On-Treatment Remission in Plaque Psoriasis as 0% BSA and MD global=0 for at least 6 months while on treatment. For both clinical practice and clinical trials. jamanetwork.com/journals/jam...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.